Clinical Trial Update: TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk [Phase 4]

View source ↗

Summary

Phase 4 trial update on ticagrelor (Brilinta) for reducing stent thrombosis and acute myocardial infarction risk in ST-elevation myocardial infarction patients;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction
• Stent Thrombosis

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: STEMI - ST Elevation Myocardial Infarction, Stent Thrombosis | Phase 4 | Status: COMPLETED